Xvivo Perfusion AB (publ) (STO:XVIVO)
180.00
-2.10 (-1.15%)
Mar 9, 2026, 5:29 PM CET
Xvivo Perfusion AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 5,736 | 5,878 | 15,403 | 10,379 | 5,459 | 8,215 | Upgrade
|
| Market Cap Growth | -61.46% | -61.84% | 48.41% | 90.12% | -33.55% | -8.90% | Upgrade
|
| Enterprise Value | 5,569 | 5,722 | 14,978 | 9,810 | 5,150 | 7,936 | Upgrade
|
| Last Close Price | 182.10 | 186.60 | 489.00 | 329.50 | 183.00 | 278.50 | Upgrade
|
| PE Ratio | 227.96 | 233.59 | 89.46 | 113.04 | 296.26 | 1007.78 | Upgrade
|
| Forward PE | 54.20 | 51.19 | 92.61 | 199.34 | 111.93 | 211.39 | Upgrade
|
| PS Ratio | 7.06 | 7.24 | 18.73 | 17.37 | 13.15 | 31.80 | Upgrade
|
| PB Ratio | 2.71 | 2.78 | 7.14 | 5.34 | 3.82 | 6.39 | Upgrade
|
| P/TBV Ratio | 3.92 | 4.01 | 10.81 | 7.84 | 6.86 | 10.06 | Upgrade
|
| P/FCF Ratio | - | 58.16 | 379.77 | 3172.09 | 564.50 | - | Upgrade
|
| P/OCF Ratio | 56.76 | 58.16 | 138.41 | 224.23 | 195.98 | - | Upgrade
|
| EV/Sales Ratio | 6.86 | 7.05 | 18.21 | 16.42 | 12.40 | 30.71 | Upgrade
|
| EV/EBITDA Ratio | 40.21 | 41.32 | 135.06 | 515.41 | 387.15 | - | Upgrade
|
| EV/EBIT Ratio | 63.01 | 64.75 | 167.53 | 1818.08 | 1156.32 | - | Upgrade
|
| EV/FCF Ratio | - | 56.62 | 369.29 | 2998.27 | 532.54 | - | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.06 | 0.02 | 0.02 | 0.01 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.90 | 0.90 | 0.28 | 1.06 | 0.51 | - | Upgrade
|
| Debt / FCF Ratio | 1.23 | 1.23 | 0.84 | 9.61 | 1.03 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.08 | -0.08 | -0.18 | -0.26 | -0.16 | -0.31 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.21 | -1.21 | -3.44 | -27.04 | -17.78 | 33.59 | Upgrade
|
| Net Debt / FCF Ratio | -1.66 | -1.66 | -9.41 | -157.29 | -24.46 | 17.66 | Upgrade
|
| Asset Turnover | 0.34 | 0.34 | 0.36 | 0.30 | 0.25 | 0.19 | Upgrade
|
| Inventory Turnover | 0.89 | 0.89 | 1.12 | 1.23 | 1.29 | 1.02 | Upgrade
|
| Quick Ratio | 3.68 | 3.68 | 3.14 | 4.94 | 2.60 | 4.43 | Upgrade
|
| Current Ratio | 5.77 | 5.77 | 4.58 | 6.15 | 3.47 | 5.24 | Upgrade
|
| Return on Equity (ROE) | 1.18% | 1.18% | 8.39% | 5.44% | 1.36% | 0.71% | Upgrade
|
| Return on Assets (ROA) | 2.31% | 2.31% | 2.43% | 0.17% | 0.17% | -0.87% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.97% | 3.10% | 4.80% | 0.40% | 0.35% | -2.41% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.90% | 3.90% | 4.00% | 0.30% | 0.30% | -1.30% | Upgrade
|
| Earnings Yield | 0.44% | 0.43% | 1.12% | 0.89% | 0.34% | 0.10% | Upgrade
|
| FCF Yield | - | 1.72% | 0.26% | 0.03% | 0.18% | -0.27% | Upgrade
|
| Buyback Yield / Dilution | 0.29% | 0.29% | -5.73% | -1.39% | -2.04% | -6.49% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.